Sementis’ quest for an Australian second-generation COVID-19 vaccine
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a...
Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.
Read more at News-Medical.Net here.
Read more at biorXiv here.